Periodontal assessment of postmenopausal women receiving risedronate
- 1 November 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Menopause
- Vol. 12 (6), 685-690
- https://doi.org/10.1097/01.gme.0000184421.50696.34
Abstract
The purpose of this study was to compare periodontal status of postmenopausal women with mild to moderate osteoporosis who use risedronate therapy with those who do not. In this cross-sectional study, a total of 60 age-matched postmenopausal women with mild to moderate osteoporosis diagnosed by a bone density scan T score below −2.5 at either spine or hip were divided into two groups. Women in the experimental group had used systemic risedronate once weekly (35 mg) for at least 3 months. Women in the control group had never used bisphosphonate therapy. The periodontal status of each subject was evaluated through a clinical periodontal examination including evaluation of periodontal probing depth, gingival recession, gingival index, plaque score, attachment loss, and alveolar bone level. The significance in differences between the two groups was assessed using two-tailed paired t tests. Significant differences (P < 0.05) were found between risedronate and control groups for periodontal probing depth (2.6 vs 2.9 mm), gingival index (0.37 vs 0.71), plaque score (56.2 vs 77.0), attachment loss (2.8 vs 3.2 mm), and alveolar bone level (3.1 and 4.0), respectively. Gingival recession parameters did not differ significantly. Five of six periodontal parameters evaluated show that postmenopausal women with mild to moderate osteoporosis using risedronate therapy have healthier periodontal status than those who do not use bisphosphonates. Women using risedronate therapy show significantly less plaque accumulation, less gingival inflammation, lower probing depths, less periodontal attachment loss, and greater alveolar bone levels. These observations suggest that risedronate therapy may play a beneficial role in periodontal status.Keywords
This publication has 10 references indexed in Scilit:
- Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 casesJournal of Oral and Maxillofacial Surgery, 2004
- Obesity and Periodontal Disease in Young, Middle‐Aged, and Older AdultsThe Journal of Periodontology, 2003
- Disodium clodronate in the treatment of diffuse sclerosing osteomyelitis (DSO) of the mandibleInternational Journal of Oral & Maxillofacial Surgery, 2001
- Effects of Bisphosphonate on Matrix Metalloproteinase Enzymes in Human Periodontal Ligament CellsThe Journal of Periodontology, 2000
- Post‐menopausal bone loss and its relationship to oral bone lossPeriodontology 2000, 2000
- MMP Inhibition and Downregulation by BisphosphonatesAnnals of the New York Academy of Sciences, 1999
- Effects of a Bisphosphonate on Experimental Periodontitis in MonkeysThe Journal of Periodontology, 1992
- The Plaque Control RecordThe Journal of Periodontology, 1972
- Periodontal Disease in Pregnancy II. Correlation Between Oral Hygiene and Periodontal ConditionActa Odontologica Scandinavica, 1964
- Periodontal Disease in Pregnancy I. Prevalence and SeverityActa Odontologica Scandinavica, 1963